Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms

doi:10.3748/wjg.v23.i28.5216

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8704)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-9) series.

Item

Count

PDF

623

WORD

208

HTML

3919

Figures (1-7)

251

Tables (1-9)

234

Sum=5235

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1039

Download

2430

Sum=3469

Jul 28, 2017 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Jul 28, 2017; 23(28): 5216-5228
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5216

Open in New Tab Full Size Figure Download Figure

Figure 1 Changes in the gastroesophageal reflux and dyspepsia-therapeutic efficacy and satisfaction test scores at baseline and after 4 wk of proton pump inhibitor therapy. Q1: Heartburn; Q2: Regurgitation; Q3: Epigastric pain/burning; Q4: Postprandial fullness; Q5: Early satiation; Q6: Dissatisfaction with eating; Q7: Dissatisfaction with sleeping; Q8: Dissatisfaction with daily activity; Q9: Dissatisfaction with mood. DS-SS: Dissatisfaction with daily life subscale.

Open in New Tab Full Size Figure Download Figure

Figure 2 Rate of responders based on a “residual symptom rate ≤ 50%” definition after 4 wk of proton pump inhibitor therapy.

Open in New Tab Full Size Figure Download Figure

Figure 3 Distribution of patient’s impressions of therapy (Q11) and the rate of responders based on a “patient’s impression of improved or better” definition after 4 wk of proton pump inhibitor therapy.

Open in New Tab Full Size Figure Download Figure

Figure 4 Distribution of numeric rating scale scores (Q12) and the rate of responders based on a “numeric rating scale ≤ 5” definition after 4 wk of proton pump inhibitor therapy.

Open in New Tab Full Size Figure Download Figure

Figure 5 Changes in the gastroesophageal reflux and dyspepsia-therapeutic efficacy and satisfaction test scores of responders and non-responders based on a “residual symptom rate ≤ 50%” definition at baseline and after 4 wk of proton pump inhibitor therapy. Q1: Heartburn; Q2: Regurgitation; Q3: Epigastric pain/burning; Q4: Postprandial fullness; Q5: Early satiation; Q6: Dissatisfaction with eating; Q7: Dissatisfaction with sleeping; Q8: Dissatisfaction with daily activity; Q9: Dissatisfaction with mood. DS-SS: Dissatisfaction with daily life subscale.

Open in New Tab Full Size Figure Download Figure

Figure 6 Changes in the gastroesophageal reflux and dyspepsia-therapeutic efficacy and satisfaction test scores of responders and non-responders based on a “patient’s impression of improved or better” definition at baseline and after 4 wk of proton pump inhibitor therapy. Q1: Heartburn; Q2: Regurgitation; Q3: Epigastric pain/burning; Q4: Postprandial fullness; Q5; Early satiation; Q6: Dissatisfaction with eating; Q7: Dissatisfaction with sleeping; Q8: Dissatisfaction with daily activity; Q9: Dissatisfaction with mood. DS-SS: Dissatisfaction with daily life subscale.

Open in New Tab Full Size Figure Download Figure

Figure 7 Changes in the gastroesophageal reflux and dyspepsia-therapeutic efficacy and satisfaction test scores of responders and non-responders based on a “numeric rating scale ≤ 5” definition at baseline and after 4 wk of proton pump inhibitor therapy. Q1: Heartburn; Q2: Regurgitation; Q3: Epigastric pain/burning; Q4: Postprandial fullness; Q5: Early satiation; Q6: Dissatisfaction with eating; Q7: Dissatisfaction with sleeping; Q8: Dissatisfaction with daily activity; Q9: Dissatisfaction with mood. DS-SS: Dissatisfaction with daily life subscale.

Citation: Nakada K, Matsuhashi N, Iwakiri K, Oshio A, Joh T, Higuchi K, Haruma K. Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms. World J Gastroenterol 2017; 23(28): 5216-5228
URL: https://www.wjgnet.com/1007-9327/full/v23/i28/5216.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i28.5216